SOPH

SOPHIA GENETICS SA

SOPH·H82027105·US·Common Stock·Healthcare - Health Information Services-13D/G

SOPH (SOPHIA GENETICS SA) is held by 40 institutional investors as of Q2 2026. Largest holders: GENERATION INVESTMENT MANAGEMENT LLP ($39.2M), AKRE CAPITAL MANAGEMENT LLC ($21.5M), ROYCE & ASSOCIATES LP ($19.5M). Net institutional sentiment: Bullish.

40
Holders
(2 Elite)
$138.8M
Total Value
70% (37)
Consensus
26 buying - 11 selling
13F: Insider & Congress: Updated regularly
SOPH

Smart Money Verdict

View all
Loading verdict
Held by 40 funds
2 elite

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders Oct 7, 2026 · Activists Feb 11, 2026 · Congress none

InsiderPKPuylaert KevinSell $1KOct 5, 2026
InsiderXZXu ZhenyuSell $60KOct 5, 2026
InsiderVDVan Well DaanSell $50KOct 5, 2026
Checking access…

Top Holders

Checking access…
Action
Unchanged
6.8M$39.2M0.4%-55.41%
0
Unchanged
3.7M$21.5M0.4%+79.90%
0
Increased
3.4M(+86.2%)$19.5M0.2%+43.14%
53
Increased
2.4M(+67.8%)$13.6M0.0%-3.16%
41
New
2.2M$12.8M0.0%+22.88%
39
Unchanged
2.2M$12.7M0.1%-10.80%
0
New
1.4M$8.2M0.1%+22.88%
38
Decreased
444,654(-0.1%)$2.6M0.0%+92.35%
0
Decreased
165,045(-53.9%)$952,3030.0%+72.93%
0
Decreased
141,992(-25.3%)$819,2940.0%+118.46%
0
Increased
138,409(+1264.7%)$798,6200.0%+25.76%
40
Increased
113,300(+89.5%)$653,7410.0%+39.89%
38
Decreased
112,133(-24.8%)$647,0070.0%+129.45%
0
New
108,062$623,5180.0%+22.88%
34
New
103,521$597,3160.0%+22.88%
34
Increased
99,124(+7.6%)$571,9450.0%+21.67%
18
Decreased
81,444(-11.7%)$469,9320.0%+59.43%
0
Increased
58,333(+472.0%)$336,5810.0%+29.43%
38
New
57,140$329,6980.0%+22.88%
33
New
38,497$222,1280.0%+22.88%
35

Showing 1-20 of 44

1 / 3
SOPHSOPHSOPHIA GENETICS SA

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used